1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Aptalis

Anonymous board for Aptalis


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    9
    Views:
    6,001
  2. anonymous
    Replies:
    1
    Views:
    2,501
  3. Anonymous
    Replies:
    33
    Views:
    17,801
  4. Anonymous
    Replies:
    14
    Views:
    10,267
  5. Anonymous
    Replies:
    38
    Views:
    12,684
  6. Anonymous
    Replies:
    24
    Views:
    11,495
  7. Anonymous
    Replies:
    17
    Views:
    7,948
  8. Anonymous
    Replies:
    9
    Views:
    4,586
  9. Anonymous
    Replies:
    3
    Views:
    3,296
  10. Anonymous
    Replies:
    13
    Views:
    5,058
  11. Downfall14
    Replies:
    13
    Views:
    4,730
  12. Spanks
    Replies:
    148
    Views:
    55,561
  13. Anonymous
    Replies:
    3
    Views:
    3,256
  14. Anonymous
    Replies:
    50
    Views:
    20,582
  15. Anonymous
    Replies:
    52
    Views:
    16,097
  16. Anonymous
    Replies:
    41
    Views:
    12,035
  17. Anonymous
    Replies:
    3
    Views:
    3,286
  18. Anonymous
    Replies:
    0
    Views:
    3,077
  19. Anonymous
    Replies:
    8
    Views:
    4,182
  20. Anonymous
    Replies:
    15
    Views:
    8,099

Thread Display Options

Loading...